These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Rhodes ME, Li PK, Burke AM, Johnson DA. Brain Res; 1997 Oct 31; 773(1-2):28-32. PubMed ID: 9409701 [Abstract] [Full Text] [Related]
3. Chronic steroid sulfatase inhibition by (p-O-sulfamoyl)-N-tetradecanoyl tyramine increases dehydroepiandrosterone sulfate in whole brain. Johnson DA, Rhodes ME, Boni RL, Li PK. Life Sci; 1997 Oct 31; 61(24):PL 355-9. PubMed ID: 9399636 [Abstract] [Full Text] [Related]
4. Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-O-sulfamate. Li PK, Rhodes ME, Jagannathan S, Johnson DA. Brain Res Cogn Brain Res; 1995 Oct 31; 2(4):251-4. PubMed ID: 8580738 [Abstract] [Full Text] [Related]
5. The effect of steroid sulfatase inhibition on learning and spatial memory. Johnson DA, Wu T, Li P, Maher TJ. Brain Res; 2000 May 26; 865(2):286-90. PubMed ID: 10821934 [Abstract] [Full Text] [Related]
10. The steroid sulfatase inhibitor COUMATE attenuates rather than enhances access of dehydroepiandrosterone sulfate to the brain in the mouse. Nicolas LB, Fry JP. Brain Res; 2007 Oct 12; 1174():92-6. PubMed ID: 17868658 [Abstract] [Full Text] [Related]
13. Immune enhancing effects of dehydroepiandrosterone and dehydroepiandrosterone sulphate and the role of steroid sulphatase. Suitters AJ, Shaw S, Wales MR, Porter JP, Leonard J, Woodger R, Brand H, Bodmer M, Foulkes R. Immunology; 1997 Jun 12; 91(2):314-21. PubMed ID: 9227333 [Abstract] [Full Text] [Related]
14. Inhibition of dehydroepiandosterone sulfate action in androgen-sensitive tissues by EM-1913, an inhibitor of steroid sulfatase. Roy J, Lefebvre J, Maltais R, Poirier D. Mol Cell Endocrinol; 2013 Aug 25; 376(1-2):148-55. PubMed ID: 23806558 [Abstract] [Full Text] [Related]
15. Nonsteroidal compounds designed to mimic potent steroid sulfatase inhibitors. Ciobanu LC, Luu-The V, Poirier D. J Steroid Biochem Mol Biol; 2002 Mar 25; 80(3):339-53. PubMed ID: 11948019 [Abstract] [Full Text] [Related]
16. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor. Purohit A, Woo LW, Singh A, Winterborn CJ, Potter BV, Reed MJ. Cancer Res; 1996 Nov 01; 56(21):4950-5. PubMed ID: 8895749 [Abstract] [Full Text] [Related]
17. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines. Selcer KW, Hegde PV, Li PK. Cancer Res; 1997 Feb 15; 57(4):702-7. PubMed ID: 9044848 [Abstract] [Full Text] [Related]
18. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Purohit A, Williams GJ, Howarth NM, Potter BV, Reed MJ. Biochemistry; 1995 Sep 12; 34(36):11508-14. PubMed ID: 7547880 [Abstract] [Full Text] [Related]
19. Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase. Boivin RP, Luu-The V, Lachance R, Labrie F, Poirier D. J Med Chem; 2000 Nov 16; 43(23):4465-78. PubMed ID: 11087571 [Abstract] [Full Text] [Related]
20. Steroid sulfatase in the human hair follicle concentrates in the dermal papilla. Hoffmann R, Rot A, Niiyama S, Billich A. J Invest Dermatol; 2001 Dec 16; 117(6):1342-8. PubMed ID: 11886493 [Abstract] [Full Text] [Related] Page: [Next] [New Search]